Human Milk Oligosaccharides Market Size (2023-2030)

The global human milk oligosaccharides market was worth USD 126.2 billion in 2022 and is expected to reach USD 335.6 billion by 2030 with a CAGR of 13.8% during the forecast period 2022-2030. 

Industry Overview:

Human Milk Oligosaccharides (HMOs) are the necessary ingredients of breast milk and exist in different compositions and concentrations in human milk. HMOs are a group of structurally varied sugars separated by glycans. HMOs are the sugars present in human breast milk and are the third-most solid component. 

HMOs, promote the essential advantages related to digestion, immunity, and mental health. The main aim of HMO comprises of prevention of infection, prebiotic effects, and supply of sialic acid for brain development. HMO is a complicated bioactive sugar molecule present in human milk. 

COVID Impact on the global Human Milk Oligosaccharides Market:

The novel coronavirus has created a positive impact on the human milk oligosaccharides market. During the lockdown, the supply chain disturbance has created a supply-demand gap, but the gap is expected to be filled soon to the post-covid. The HMOs sales volume has increased tremendously during the pandemic period providing immunity-boosting features. 

Market Drivers:

The rising demand for food supplements, the ease of availability of infant formula, and growing awareness of health in people drive the HMOs market further. The demand for HMOs has spurred the use of various nutritional products used as food and dietary supplements. The quick development in the dairy industry, growing health awareness, and technological advancements boom the HMOs market. By 2050, the global population is expected to grow by nearly 1 billion in the upcoming ten years, reaching 9.5 million, as per the World Health Organization. 

The use of HMOs in food supplements, and other functional food and beverages products help in treating particular health disorders, and high-risk health conditions which drive the human milk oligosaccharides market growth throughout the forecast period. The increasing disposable income, rising difficulties of diabetes, high blood pressure, and gut diseases, and mounting awareness about health and hygiene flourish the HMOs market growth. 

The demand for infant nutrition products is nourishing as the global population is expanding, and the demand for infant formula is extremely strong. The availability of new technologies like the enzymatic transglycosylation process to artificially synthesize HMOs booming the market growth. 

Market Restraints:

The cost factor of the research and developments is expensive, shortage of technology for large scale technology and stringent government rules are likely to hinder the human milk oligosaccharides market growth.

HUMAN MILK OLIGOSACCHARIDES MARKET REPORT COVERAGE:

Segment Analysis:

The global Human Milk Oligosaccharides Market has been segmented and sub-segmented based on product, type, and application.

Human Milk Oligosaccharides Market - By Product

• 2’FL

• 3’FL

• 3’SL

• 6’SL

• Lacto-N-Neotetraose

• Lacto-N-tetraose

Lacto-N-Neotetraose accounts for the largest share in terms of revenue in 2020 due to the increase in growth of beneficial bifidobacteria and the downfall in the growth of pathogenic bacteria attracting the food and beverages manufacturers resulting in growing awareness. 2’FL is scheduled to grow at a speedy rate as a dietary supplement as it is capable of modifying gut microbial composition and behavior from formula-powered infants receiving extra feeding. 

Human Milk Oligosaccharides Market - By Type

• Neutral

• Acidic

By type, the neutral segment holds a lion's share in the human milk oligosaccharides market. The neutral products perform as prebiotics to surge the growth of advantageous intestinal bacteria. The neutral type is used mainly as a useful material in products like infant formulas, medicinal food, and pharmaceutical. 

Human Milk Oligosaccharides Market - By Application

• Infant Formula

• Functional Food & Beverages

• Food Supplements

• Others

The infant formula application holds the highest share in the human milk oligosaccharides market. The segment growth attributes to the rising demand for infant mortality rate with growth factors of the parents associated with the health and safety of their babies. HMOs, help in keeping gastrointestinal diseases at the creek. Infant formula plays a critical lead in brain development and memory improvement among humans. Moreover, infant formula is obtained from bovine milk which consists of low oligosaccharides compared to those obtained from human milk. 

Human Milk Oligosaccharides Market - By Regional Analysis

• North America registered significant growth in the human milk oligosaccharide market due to the rising consumption of functional food and beverages. The market is expected to lead the market in terms of share. The existence of massive significant infant formula and baby food manufacturers along with the advanced technologies is to boom the human milk oligosaccharides market. In the U.S., HMOs are intentionally used in food compared to dietary supplements, governed by the Generally Governed as Safe (GRAS). In the U.S., DuPont's CARE4U was GRAS-approved for use in infant formula and toddler foods. 

• The European human milk oligosaccharides market is observing promising growth during the mentioned period. The growing consumption of dietary supplements, particularly the elderly people mount the market growth. In Europe, the demand for infant food is surging with the existence of a large number of HMO manufacturers, and regular approvals for HMO as a primary ingredient in HMO augmenting the Human milk oligosaccharides market. Countries like Italy, France, and Germany are the largest consumers of dietary supplements. In Europe, two HMOs were approved by the novel food and safety assessment.  

• However, Asia-Pacific is estimated to be the briskest growing region in the human milk oligosaccharides market owing to the untapped market. China is witnessing the highest share in the HMO market in 2019. 

• In countries like Singapore, China, the Philippines, and Malaysia, countries are expected to hold strong HMO-based supplements further. In China, a tremendous increase in demand for infant formulas and continues to grab the focus of milk producers. China imports a high quantity of infant formulations from other countries.

• Latin America and the Middle East & African regions are anticipated to have notable growth in the upcoming years due to growing consumer awareness about health and hygiene in infants and rising technologies.

Human Milk Oligosaccharides Market - Key Players:

1. Inbiose NV

2. Elicityl S.A.

3. Jennewein Biotechnologie GmbH

4. Glycom A/S

5. Medolac Laboratories

6. ZuChem Inc.

7. Glycosyn LLC 

In July 2017, Nestle Spain launched a new infant formula that reproduces two human milk oligosaccharides and the ingredients are approved by the European Food Safety Authority and the US FDA. 

Recent Developments

• On September 22, 2020, Jennewein Biotechnologies and Chr. Hansen A/S agreed to obtain all the shares of Jennewein Technologies and invest hugely in producing HMOs and increases the demand for HMOs. https://www.prnewswire.com/news-releases/jennewein-biotechnologie-gmbh-and-chr-hansen-as-to-join-forces-in-high-growth-human-milk-oligosaccharides-market-301135722.html

• On October 23, 2019, BASF joined the HMO club with a 2'-FL launch. The ingredient is launched in partnership with the biotechnology firm Glycosyn. https://www.nutraingredients-usa.com/Article/2019/10/23/BASF-joins-the-HMO-club-with-2-FL-launch

• On February 21, 2020, Royal DSM purchased Glycom A/S on collaborating with Nestle, for producing infant formula supplement, Lactate at a low cost. https://european-biotechnology.com/up-to-date/latest-news/news/royal-dsm-acquires-glycom-as-for-eur765m.html